Inhibition of phosphodiesterase 2 reverses impaired cognition and neuronal remodeling caused by chronic stress.
Inhibition of phosphodiesterase 2 reverses impaired cognition and neuronal remodeling caused by chronic stress.
复制标题
DOI:
10.1016/j.neurobiolaging.2014.08.028
复制
发表时间:
2015-02
影响因子:
4.2
通讯作者:
O'Donnell JM
中科院分区:
文献类型:
--
作者:
Xu Y;Pan J;Sun J;Ding L;Ruan L;Reed M;Yu X;Klabnik J;Lin D;Li J;Chen L;Zhang C;Zhang H;O'Donnell JM
Chronic stress and neuronal vulnerability have recently been recognized as factors contributing to cognitive disorders. One way to modify neuronal vulnerability is through mediation of phosphodiesterase 2 (PDE2), an enzyme that exerts its action on cognitive processes via the control of intracellular second messengers, cGMP and, to a lesser extent, cAMP. This study explored the effects of a PDE2 inhibitor, Bay 60-7550, on stress-induced learning and memory dysfunction in terms of its ramification on behavioral, morphological and molecular changes. Bay 60-7550 reversed stress-induced cognitive impairment in the Morris water maze (MWM), novel object recognition and location tasks (ORT/OLT), effects prevented by treatment with 7-NI, a selective inhibitor of neuronal nitric oxide synthase (nNOS); MK801, a glutamate receptor (NMDAR) inhibitor; myr-AIP, a CaMKII inhibitor; and KT5823, a PKG inhibitor. Bay 60-7550 also ameliorated stress-induced structural remodeling in the CA1 of the hippocampus, leading to increases in dendritic branching, length, and spine density. However, the neuroplasticity initiated by Bay 60-7550 was not seen in the presence of 7-NI, MK801, myr-AIP or KT5823. PDE2 inhibition reduced stress-induced ERK activation and attenuated stress-induced decreases in transcription factors (e.g., Elk-1, TORC1, and pCREB) and plasticity-related proteins (e.g, Egr-1 and BDNF). Pre-treatment with inhibitors of NMDA, CaMKII, nNOS, PKG (or PKA), blocked the effects of Bay 60-7550 on cGMP or cAMP signaling. These findings indicate that the effect of PDE2 inhibition on stress-induced memory impairment is potentially mediated via modulation of neuroplasticity-related, NMDAR-CaMKII-cGMP/cAMP signaling.
登录
查看更多内容
影响因子:
2.7
作者:
de Lima, MNM;Laranja, DC;Schröder, N
通讯作者:
Schröder, N
DOI:
10.1523/jneurosci.5236-10.2011
发表时间:
2011-01-05
期刊:
The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子:
--
作者:
Li YF;Cheng YF;Huang Y;Conti M;Wilson SP;O'Donnell JM;Zhang HT
通讯作者:
Zhang HT
DOI:
10.1073/pnas.0908563106
发表时间:
2009-10-20
影响因子:
11.1
作者:
Hains, Avis Brennan;Vu, Mai Anh T.;Arnsten, Amy F. T.
通讯作者:
Arnsten, Amy F. T.
DOI:
10.1098/rstb.2001.0947
发表时间:
2001-09-29
影响因子:
6.3
作者:
Clayton, NS;Griffiths, DP;Dickinson, A
通讯作者:
Dickinson, A
影响因子:
3.7
作者:
Cho T;Ryu JK;Taghibiglou C;Ge Y;Chan AW;Liu L;Lu J;McLarnon JG;Wang YT
通讯作者:
Wang YT